Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
Here's Warren Buffett's stock portfolio changes
05:38am, Wednesday, 15'th Nov 2023
Berkshire Hathaway (NYSE: BRKA, BRKB) announced to the Security and Exchange Commission (SEC) its Q3 re port on Tuesday, November 14, which tells an interesting story of new acquisitions, reductions,
Blue-Chip Bargains: Top 3 Oversold Aristocrats for Value Investors
11:23pm, Tuesday, 14'th Nov 2023
Need help boosting your long-term portfolio gains? Well, you're in luck.
It's Time to Buy These 3 Dividend Aristocrats Trading Near 52-Week Lows
10:20pm, Tuesday, 14'th Nov 2023
If you're a dividend investor, there is nothing more attractive than dividend aristocrats, those S&P 500 companies that have increased their annual dividend payment for 25 consecutive years or more.
Warren Buffett's Berkshire Hathaway Sheds Investments in GM, J&J, P&G
09:51pm, Tuesday, 14'th Nov 2023
Berkshire's stock portfolio is concentrated in five companies: Apple, Bank of America, American Express, Coca-Cola and Chevron.
All Dividend Companies Have One Big Problem In Common
01:00pm, Tuesday, 14'th Nov 2023
Dividend investing is struggling in the current macroeconomic environment due to high interest rates. The yield on T-Bonds disincentivizes investors from buying dividend companies, leading to a drop i
Strategic Portfolio Allocation With Risk/Reward Optimization: A Deep Dive Into My Dividend Portfolio
01:00pm, Saturday, 11'th Nov 2023
In today's article, I will show you the current allocation of the 20 largest positions of my personal investment portfolio. I will demonstrate that the portfolio is relatively concentrated, with 5 pos
Cautious Investor? 2 Safe Stocks You Also Can Count on For Growth
05:00am, Saturday, 11'th Nov 2023
Eli Lilly just gained approval for a drug that could win big in the multibillion-dollar weight-loss market. Johnson & Johnson is focusing on its high-growth businesses after the recent spinoff of its
5 Dividend Aristocrats Stocks Have Raised Their Dividends For Over 60 Years
09:30am, Thursday, 09'th Nov 2023
With November here, many investors are looking toward Thanksgiving, the holidays, and the end of the year.
3 Dividend Stocks to Buy for Consistent Income
05:35am, Thursday, 09'th Nov 2023
In the dynamic world of investing, dividend stocks have always been a consistent way for investors to generate income. These stalwarts not only offer a steady income stream but also demonstrate the po
Grab these 2 funds with rich 11%-12% yields while you can
07:18am, Wednesday, 08'th Nov 2023
With much of the U.S. stock market in a correction there are plenty of attractive stocks to consider. This is especially true in income investing.
5 Kings And Aristocrats Selling At Decade High Dividend Yields
04:21am, Wednesday, 08'th Nov 2023
The Market believes the Fed may pause rate hikes and soon pivot, leading to increased demand for 10-year Treasury bonds. Long-duration US Treasuries may not be a good investment unless they yield more
Johnson & Johnson's surgical robot could participate in clinical trials next year following FDA application
10:59am, Tuesday, 07'th Nov 2023
Johnson & Johnson's (NYSE:JNJ) MedTech unit plans to submit an application to the US Food and Drug Administration that would allow it to launch clinical trials of a four-armed surgical robot in the s
2 Magnificent Dividend Stocks Trading Near 52-Week Lows to Buy Now and Hold at Least a Decade
05:37am, Tuesday, 07'th Nov 2023
The stock market recently finished its best week of the year, but there are a couple of terrific dividend stocks still down near their 52-week lows. Johnson & Johnson doesn't sell Baby Powder anymore,
November Dogs Of The Dow: 3 Buyable, 4 Watchable
04:28pm, Monday, 06'th Nov 2023
"The Dow® [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation.is also a consideration.�
IHE: You Better Like Eli Lilly And Johnson & Johnson To Buy This
03:44pm, Monday, 06'th Nov 2023
The iShares U.S. Pharmaceuticals ETF provides targeted exposure to the U.S. pharmaceutical industry but has a highly concentrated portfolio. The IHE ETF's top five holdings, including Eli Lilly and Jo
